Lithuanian generic pharmaceuticals company Sanitas announced that it would sell part of the HBM Pharma company in Slovakia to Latvian company Liplats 2000. The company is selling only manufacturing part of the company, while other departments will be retained by Sanitas. The deal's value is yet to be determined and will be disclosed upon the closure of the transaction according to the financial position of target company. Liplats 2000 main shareholders are shareholders of Latvian generic pharmaceuticals company Grindeks. The deal is expected to be closed in the two months period.
|
Estonian national airline Estonian Air recorded net loss of EUR 49.2mn in 2012, up from net loss of EUR 17.3mn in 2011. Operating loss amounted to EUR 35.8mn in 2012. Revenues of the company ... more
Lithuanian flour manufacturer Malsena announced that it has acquired Latvian flour manufacturer Rigas Dzirnavieks. The company indicates that with the acquisition it will become the largest flour ... more
Estonian national airline Estonian Air announced that it agreed to pay penalties for returning two excess Embraer E190 aircrafts to the manufacturer. The company has started restructuring and ... more